This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
The role of prostate-specific antigen in light of new scientific evidence - Abstract
May 31, 2013
Automatic prostate tracking and motion assessment in volumetric modulated arc therapy with an electronic portal imaging device - Abstract
May 31, 2013
Targeting bone physiology for the treatment of metastatic prostate cancer - Abstract
May 31, 2013
A phase II trial of androgen deprivation therapy (ADT) plus chemotherapy as initial treatment for local failures or advanced prostate cancer - Abstract
May 31, 2013
The dilemma of localizing disease relapse after radical treatment for prostate cancer: Which is the value of the actual imaging techniques? - Abstract
May 30, 2013
Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: Long-term outcomes - Abstract
May 30, 2013
Multiparametric magnetic resonance imaging of prostate cancer - Abstract
May 30, 2013
The diagnostic value of conventional MRI in the differentiation of malignant tumor from benign lesion in prostatic peripheral zone - Abstract
May 30, 2013
Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment - Abstract
May 30, 2013
Focal brachytherapy for selected low-risk prostate cancers: A pilot study - Abstract
May 30, 2013
Podcast: Castration-resistant prostate cancer: AUA Guideline 2013 commentary, by E. David Crawford, MD
May 30, 2013
Prevalence of patients with nonmetastatic prostate cancer on androgen deprivation therapy in the United States - Abstract
May 30, 2013
Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies - Abstract
May 30, 2013
Interstitial hyperthermia of the prostate in combination with brachytherapy: An evaluation of feasibility and early tolerance - Abstract
May 30, 2013
Enzalutamide: An evidence-based review of its use in the treatment of prostate cancer - Abstract
May 30, 2013
AUA 2013 - Slide Lecture: Introducing a new option before chemotherapy for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
May 30, 2013
Minireview: Androgen metabolism in castration-resistant prostate cancer - Abstract
May 29, 2013
Magnetic resonance imaging for prostate cancer clinical application - Abstract
May 29, 2013
Prostate HistoScanning: A screening tool for prostate cancer? - Abstract
May 29, 2013
Assessment of screenees' knowledge on prostate cancer: Results of a questionnaire using the Fact Sheet - Abstract
May 29, 2013
Page 1158 of 1439
Start
Prev
1153
1154
1155
1156
1157
1158
1159
1160
1161
1162
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free